Literature DB >> 25375792

Attitudes of serodiscordant couples towards antiretroviral-based HIV prevention strategies in Kenya: a qualitative study.

Nikola Fowler1, Paul Arkell, Michael Abouyannis, Catherine James, Lesley Roberts.   

Abstract

This qualitative study aims to gain in-depth information about the attitudes of HIV-serodiscordant couples towards two new methods of HIV prevention; Pre-Exposure Prophylaxis and Treatment as Prevention, both of which have been recently recommended by the World Health Organisation. Semi-structured interviews were conducted with 38 individuals in a serodiscordant relationship in Western Kenya. Topic guides were used to elicit information on perceived benefits, concerns, and preferences towards Treatment as Prevention and Pre-Exposure Prophylaxis. Data evaluation and thematic generation were developed using framework analysis. Results suggest that the majority of participants, irrespective of gender and HIV status, found Treatment as Prevention the more acceptable strategy. Key factors influencing this decision were HIV-negative participants' limited motivation to take prophylactic antiretrovirals and the likely health improvements Treatment as Prevention offers HIV-positive partners. However, issues were raised concerning the likelihood of low concurrent condom use and poor medication adherence when using these preventative approaches. It was concluded that the adoption of Treatment as Prevention as a method of HIV control in Kenya is likely to be more readily accepted by serodiscordant couples than Pre-exposure Prophylaxis. However, future implementation of either strategy would require measures to address the possibility of risk compensation and poor adherence.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25375792     DOI: 10.1089/apc.2014.0210

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  6 in total

1.  What motivates serodiscordant couples to prevent HIV transmission within their relationships: findings from a PrEP implementation study in Kenya.

Authors:  Rena C Patel; Anna M Leddy; Josephine Odoyo; Keerthana Anand; Gaelen Stanford-Moore; Imeldah Wakhungu; Elizabeth A Bukusi; Jared M Baeten; Joelle M Brown
Journal:  Cult Health Sex       Date:  2017-09-14

2.  I Knew I Would Be Safer. Experiences of Kenyan HIV Serodiscordant Couples Soon After Pre-Exposure Prophylaxis (PrEP) Initiation.

Authors:  Kenneth Ngure; Renee Heffron; Kathyrn Curran; Sophie Vusha; Mariah Ngutu; Nelly Mugo; Connie Celum; Jared M Baeten
Journal:  AIDS Patient Care STDS       Date:  2016-02       Impact factor: 5.078

Review 3.  Values and Preferences on the Use of Oral Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Multiple Populations: A Systematic Review of the Literature.

Authors:  Florence M Koechlin; Virginia A Fonner; Sarah L Dalglish; Kevin R O'Reilly; Rachel Baggaley; Robert M Grant; Michelle Rodolph; Ioannis Hodges-Mameletzis; Caitlin E Kennedy
Journal:  AIDS Behav       Date:  2017-05

4.  Uptake of Home-Based HIV Testing, Linkage to Care, and Community Attitudes about ART in Rural KwaZulu-Natal, South Africa: Descriptive Results from the First Phase of the ANRS 12249 TasP Cluster-Randomised Trial.

Authors:  Collins C Iwuji; Joanna Orne-Gliemann; Joseph Larmarange; Nonhlanhla Okesola; Frank Tanser; Rodolphe Thiebaut; Claire Rekacewicz; Marie-Louise Newell; Francois Dabis
Journal:  PLoS Med       Date:  2016-08-09       Impact factor: 11.069

5.  Good Health and Moral Responsibility: Key Concepts Underlying the Interpretation of Treatment as Prevention in South Africa and Zambia Before Rolling Out Universal HIV Testing and Treatment.

Authors:  Virginia Bond; Graeme Hoddinott; Lario Viljoen; Melvin Simuyaba; Maurice Musheke; Janet Seeley
Journal:  AIDS Patient Care STDS       Date:  2016-09       Impact factor: 5.078

6.  The landscape for HIV pre-exposure prophylaxis during pregnancy and breastfeeding in Malawi and Zambia: A qualitative study.

Authors:  Chifundo Zimba; Suzanne Maman; Nora E Rosenberg; Wilbroad Mutale; Oliver Mweemba; Wezzie Dunda; Twambilile Phanga; Kasapo F Chibwe; Tulani Matenga; Kellie Freeborn; Leah Schrubbe; Bellington Vwalika; Benjamin H Chi
Journal:  PLoS One       Date:  2019-10-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.